Exploratory study on the effect of osteoactivin on bone formation in the rat critical-size calvarial defect model

Journal of Periodontal Research

Volumn 47, Issue 2, 2012, Pages 243-247

  Bateman, J P ^a,b   Safadi, F F ^c   Susin, C ^d   Wikesjo U M E ^d  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b Temple University School of Medicine ^*  (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Bone; Craniofacial; Gpnmb protein; Osteoactivin; Rat model; Tissue engineering

Indexed keywords

DRUG CARRIER; GELATIN SPONGE; GPNMB PROTEIN, RAT; MEMBRANE PROTEIN;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE DISEASE; BONE REGENERATION; COMPARATIVE STUDY; CRANIOTOMY; DRUG EFFECT; MALE; PATHOLOGY; RANDOMIZATION; RAT; SKULL; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; BONE DISEASES; BONE REGENERATION; CRANIOTOMY; DRUG CARRIERS; GELATIN SPONGE, ABSORBABLE; MALE; MEMBRANE GLYCOPROTEINS; OSTEOGENESIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SKULL; TIME FACTORS;

EID: 84857449122     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01428.x     Document Type: Article

References (30)

1. Wikesjö UME, Qahash M, Huang YH, Xiropaidis A, Polimeni G, Susin C. Bone morphogenetic proteins for periodontal and alveolar indications; Biological observations - clinical implications. Orthod Craniofac Res 2009;12:263-270.
2. Lee J, Stavropoulos A, Susin C, Wikesjö UME. Periodontal regeneration: focus on growth and differentiation factors. Dent Clin North Am 2010;54:93-111.
3. Safadi FF, Xu J, Smock SL, Rico MC, Owen TA, Popoff SN. Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts. J Cell Biochem 2001;84:12-26.
4. Selim AA, Abdelmagid SM, Kanaan RA et al. Anti-osteoactivin antibody inhibits osteoblast differentiation and function in vitro. Crit Rev Eukaryot Gene Expr 2003;13:265-275.
5. Hadjiargyrou M, Lombardo F, Zhao S et al. Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J Biol Chem 2002;277:30177-30182.
6. Rich JN, Shi Q, Hjelmeland M et al. Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem 2003;278:15951-15957.
7. Abdelmagid SM, Barbe MF, Arango-Hisijara I, Owen TA, Popoff SN, Safadi FF. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function. J Cell Physiol 2007;210:26-37.
8. Sheng MH, Wergedal JE, Mohan S, Lau KH. Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity. FEBS Lett 2008;582:1451-1458.
9. Pang EK, Im SU, Kim CS et al. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model. J Periodontol 2004;75:1364-1370.
10. Hyun SJ, Han DK, Choi SH et al. Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects. J Periodontol 2005;76:1667-1674.
11. Hong SJ, Kim CS, Han DK et al. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. Biomaterials 2006;27:3810-3816.
12. Patel ZS, Young S, Tabata Y, Jansen JA, Wong ME, Mikos AG. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008;43:931-940.
13. Pryor ME, Polimeni G, Koo KT et al. Analysis of rat calvaria defects implanted with a platelet-rich plasma preparation: histologic and histometric observations. J Clin Periodontol 2005;32:966-972.
14. Plachokova AS, van den Dolder J, Jansen JA. The bone-regenerative properties of Emdogain adsorbed onto poly (D, L-lactic-coglycolic acid)/calcium phosphate composites in an ectopic and an orthotopic rat model. J Periodontal Res 2008;43:55-63.
15. Donos N, Lang NP, Karoussis IK, Bosshardt D, Tonetti M, Kostopoulos L. Effect of GBR in combination with deproteinized bovine bone mineral and/or enamel matrix proteins on the healing of critical-size defects. Clin Oral Implants Res 2004;15:101-111.
16. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986;205:299-308.
17. Wikesjö UME, Nilvéus R. Periodontal repair in dogs: healing patterns in large circumferential periodontal defects. J Clin Periodontol 1991;18:49-59.
18. Wikesjö UME, Kean CJ, Zimmerman GJ. Periodontal repair in dogs: supraalveolar defect models for evaluation of safety and efficacy of periodontal reconstructive therapy. J Periodontol 1994;65:1151-1157.
19. Wikesjö UME, Susin C, Qahash M et al. The critical-size supraalveolar peri-implant defect model: characteristics and use. J Clin Periodontol 2006;33:846-854.
20. Bosch C, Melsen B, Vargervik K. Importance of the critical-size bone defect in testing bone-regenerating materials. J Craniofac Surg 1998;9:310-316.
21. Gosain AK, Song L, Yu P et al. Osteogenesis in cranial defects: reassessment of the concept of critical size and the expression of TGF-beta isoforms. Plast Reconstr Surg 2000;106:360-371.
22. Huh JY, Choi BH, Kim BY, Lee SH, Zhu SJ, Jung JH. Critical size defect in the canine mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:296-301.
23. Schlegel KA, Lang FJ, Donath K, Kulow JT, Wiltfang J. The monocortical critical size bone defect as an alternative experimental model in testing bone substitute materials. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:7-13.
24. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2008;2:81-96.
25. Schmidmaier G, Schwabe P, Strobel C, Wildemann B. Carrier systems and application of growth factors in orthopaedics. Injury 2008;39(Suppl 2):S37-S43.
26. Sigurdsson TJ, Nygaard L, Tatakis DN et al. Periodontal repair in dogs: evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 1996;16:524-537.
27. Friess W, Uludag H, Foskett S, Biron R, Sargeant C. Characterization of absorbable collagen sponges as rhBMP-2 carriers. Int J Pharm 1999;187:91-99.
28. Winn SR, Uludag H, Hollinger JO. Carrier systems for bone morphogenetic proteins. Clin Orthop Relat Res 1999;367(Suppl):S95-S106.
29. Choi SH, Kim CK, Cho KS et al. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J Periodontol 2002;73:63-72.
30. Geiger M, Li RH, Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 2003;55:1613-1629.